HIGUCHI INC. Official site

A 3D printer that enables tablet manufacturing using innovative 3D printing technology, revolutionizing personalized medicine.

The M3DIMAKER, a 3D printer developed by FabRx, is a groundbreaking printer that allows the use of three different nozzles. It is managed by dedicated software, enabling the adjustment of prescribed formulations at clinical trial sites by selecting pre-registered prescriptions, thus allowing the creation of tablets. It features fingerprint authentication to restrict operational permissions, allowing only authorized individuals to operate it. Additionally, it has a monitoring camera for error checking to detect any issues that may arise during manufacturing. It can be used not only for the production of formulations tailored to individual medical needs but also for drug discovery research, formulation development, and clinical research applications.

Various lineups are prepared based on flow rate, effective surface area, and sterilization methods.

Material: Hydrophilic PES・PVDF, Hydrophobic PTFE Pore size: 0.2μm, 0.45μm Length: 25mm/37mm/50mm, 2.5 to 30 inches Sterilization: Gamma ray sterilization, autoclave, steam sterilization

Sterilization applications for biopharmaceuticals and sterile preparations! Filters with high microbial retention, low protein adsorption, and extremely low elution performance.

Material: Hydrophilic PES・PVDF, Hydrophobic PTFE Pore size: 0.1μm～ Length: 1 inch～30 inches Manufacturing: ISO Class 7 clean room 　　　*Produced and verified under a quality management system certified by ISO 9001, ensuring consistent product quality through a traceability-secured quality management system. Certification: FDA/DMF registered Remarks: Inlet and outlet shape selectable 　　　Flow rate, adsorption, pressure, temperature, bacteria challenge test 　　　Certificates for various tests

To reduce contamination risks and streamline the cleaning process.

Tube material: TPE, silicone, etc. selectable. Filter: PES, PVDF, pore size selectable. Consistent product quality under ISO13485 quality management system. Manufactured in a Class 7 cleanroom.

Corresponds to the Japanese Pharmacopoeia, USP, and EP3. The design minimizes mechanical variation factors of the device using vessels that reduce the deviation of the container's centering.

The precise and robust design, along with certified vessels, paddles, and baskets, supports tri-polar compatibility as well as compliance with FDA, ASTM, and JP17 reference information for mechanical calibration. The automatic tablet dispensing mechanism, automatic temperature monitoring, and automatic sampling mechanism, combined with the sampling station 850-DS, enable semi-automation of dissolution testing. Online analysis through the connection of a UV meter displays the dissolution rate in real-time. By selecting options tailored to customer applications, a wide range of device configurations from manual to automatic is possible.

JP17 Bureau Reference Information: Mechanical Calibration Correspondence for Dissolution Test Apparatus

Effects of introducing 280-DS MQS: - Shortened MQ tasks (2 days to 30 minutes) - Reduced calibration intervals, improving the reliability of test results - Equipment history can be investigated - Measurement results are automatically recorded from each module to the PC - Standard tablets such as prednisone are not needed

Management of test data, data integrity, dissolution testing software!

To ensure data integrity in dissolution testing, the introduction of the Agilent dissolution testing workstation is optimal. ● Compliance: 21 CFR Part 11 compliant ● Security: Access management, tamper prevention, audit trails, backups ● Efficiency: Control and data management for up to 4 dissolution testers